US Stock MarketDetailed Quotes
NUWE Nuwellis
- 1.3600
- +0.0100+0.74%
Trading Nov 19 11:23 ET
5.95MMarket Cap-22P/E (TTM)
1.4300High1.3200Low276.72KVolume1.3500Open1.3500Pre Close374.92KTurnover6.33%Turnover RatioLossP/E (Static)4.37MShares31.150052wk High1.87P/B5.95MFloat Cap1.000052wk Low--Dividend TTM4.37MShs Float6085800000.0000Historical High--Div YieldTTM8.15%Amplitude1.0000Historical Low1.3540Avg Price1Lot Size
About Nuwellis Company
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Company Profile
SymbolNUWE
Company NameNuwellis
Listing DateFeb 16, 2012
Founded1999
CEOMr. Nestor Jaramillo, Jr
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address12988 Valley View Road
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344
Phone1-952-345-4200
Company Executives
- Name
- Position
- Salary
- Nestor Jaramillo, Jr
- Director, President and Chief Executive Officer
- 606.60K
- Neil P. Ayotte, Esq.
- Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
- 406.49K
- Robert Benjamin Scott
- Chief Financial Officer and Principal Accounting Officer
- 291.41K
- John L. Erb
- Chairman of the Board
- 65.86K
- Gregory D. Waller
- Independent Director
- 68.86K
- David Alan McDonald
- Independent Director
- --
- Dr. Archelle Georgiou, M.D.
- Independent Director
- --
- Michael McCormick
- Lead Independent Director
- 25.66K
- Dr. Maria Rosa Costanzo, M.D.
- Independent Director
- 53.79K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data